News
News
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts FibroGen (FGEN) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel
05/08/2021 / 19:15 - GlobeNewswire - HUTCHMED to Attend Upcoming Investor Conferences
05/07/2021 / 13:00 - GlobeNewswire - Medicare Coverage Determination for Molecular Testing Announced for Solid Organ Allograft Rejection, Citing Multiple Publications from OncoCyte Corporation’s Subsidiary Chronix Biomedical, Inc.
05/06/2021 / 14:00 - GlobeNewswire - Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development
05/06/2021 / 13:00 - GlobeNewswire - G1 Therapeutics Provides First Quarter 2021 Financial Results and Operational Highlights
05/05/2021 / 22:01 - GlobeNewswire - Black and Latinx Surgeons Continue to Hit Glass Ceiling in America
05/05/2021 / 17:00 - GlobeNewswire - Clearlake Capital-Backed Provation Acquires iProcedures
05/04/2021 / 14:02 - GlobeNewswire - Silk Road Medical to Present at BofA Securities 2021 Virtual Health Care Conference
05/03/2021 / 22:05 - GlobeNewswire - High risk heart patients underuse hospice care options
05/03/2021 / 21:02 - GlobeNewswire - Bone Health Technologies Closes $2.5 Million Funding Round and Appoints New Board Members
05/03/2021 / 16:00 - GlobeNewswire
Real-time